Organon Analysts Cut Their Forecasts Following Q3 Results
1. OGN beat Q3 earnings expectations at $1.01 per share. 2. Quarterly sales of $1.602 billion surpassed Wall Street's estimates. 3. Fiscal sales guidance lowered below consensus, now $6.20B-$6.25B. 4. Free cash flow expected to exceed $900 million this year. 5. Shares fell 3.4% post-earnings announcement, price targets were cut.